{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:40:26Z","timestamp":1778910026846,"version":"3.51.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe the occurrence and features of Neurocystircercosis (NCC) in Qatar.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Qatar has a mixed population of natives and expats. NCC is not endemic to the region, but clinical practice suggests its occurrence in large numbers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design\/ methods<\/jats:title><jats:p>A database was created to summarize information retrospectively collected on patients with NCC seen through the national health system (HMC) between 2013 and 2018. We identified demographic and disease related variables (clinical manifestations, investigative findings, treatment and outcome) for all patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 420 identified NCC patients, 393 (93.6%) were men, and 98.3% were immigrants from NCC endemic countries such as Nepal (63.8%) and India (29.5%). Eighty percent of patients presented with seizures, with the majority (69%) experiencing generalized tonic\u2013clonic seizures. Five percent presented with status epilepticus. Headaches, the second most common complaint, were reported in 18% of subjects. On imaging, 50% had a single lesion while 63% included pathology at the calcified stage. The lesions were parenchymal in 99.5% of cases, predominantly in the frontal lobe (59%). Thirteen percent were diagnosed incidentally on imaging, mainly in the form of isolated calcified non enhancing lesions. Albendazole was received by 55% of patients, and phenytoin was the most prescribed anti-seizure drug (57%). When long term follow up was available, 70% of the patients presenting with seizures were completely seizure free.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NCC is prevalent in Qatar, mainly within the large Southeast Asian immigrant population. NCC is currently a significant contributor to the epilepsy burden in Qatar, often with a good outcome regarding seizure control. NCC with intraparenchymal single lesion shares a large proportion of our cohort.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1173909","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T10:43:59Z","timestamp":1681987439000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Neurocysticercosis in non-endemic regions: The experience of Qatar"],"prefix":"10.3389","volume":"14","author":[{"given":"Naim","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanal","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abunaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayane","family":"Melikyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El Sotouhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Wahbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"Nauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Al-Maadid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boulenouar","family":"Mesraoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Elkhider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/B978-0-7020-4088-7.00097-3","article-title":"Neurocysticercosis","volume":"121","author":"Del Brutto","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ncl.2018.07.003","article-title":"Neurocysticercosis","volume":"36","author":"Garcia","year":"2018","journal-title":"Neurol Clin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5698\/1535-7511-14.s2.23","article-title":"Neurocysticercosis and epilepsy","volume":"14","author":"Burneo","year":"2014","journal-title":"Epilepsy Curr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1212\/CPJ.0b013e31828d9f17","article-title":"Neurocysticercosis: five new things","volume":"3","author":"Carpio","year":"2013","journal-title":"Neurol Clin Pract"},{"key":"ref6","first-page":"595","article-title":"Taenia solium: WHO endemicity map update","volume":"91","author":"Donadeu","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/epi.12159","article-title":"From seizures to epilepsy and its substrates: neurocysticercosis","volume":"54","author":"Singh","year":"2013","journal-title":"Epilepsia"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/epi.12849","article-title":"Neurocysticercosis: a natural human model of epileptogenesis","volume":"56","author":"Nash","year":"2015","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/epi.13892","article-title":"On the relationship between calcified neurocysticercosis and epilepsy in an endemic village: a large-scale, computed tomography-based population study in rural Ecuador","volume":"58","author":"Del Brutto","year":"2017","journal-title":"Epilepsia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"117527","DOI":"10.1016\/j.jns.2021.117527","article-title":"Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world","volume":"427","author":"Bustos","year":"2021","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jns.2016.11.045","article-title":"Revised diagnostic criteria for neurocysticercosis","volume":"372","author":"del Brutto","year":"2017","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14737175.2020.1707667","article-title":"Twenty-five years of evolution of standard diagnostic criteria for neurocysticercosis. How have they impacted diagnosis and patient outcomes?","volume":"20","author":"Del Brutto","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"ref13","first-page":"226","article-title":"Neurocysticercosis in central Saudi Arabia","volume":"10","author":"Al-Khuwaitir","year":"2005","journal-title":"Neurosciences (Riyadh)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tmaid.2011.07.002","article-title":"Neurocysticercosis in Qatari patients: case reports","volume":"9","author":"Khan","year":"2011","journal-title":"Travel Med Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3201\/eid1901.120432","article-title":"Neurocysticercosis on the Arabian peninsula, 2003-2011","volume":"19","author":"Del Brutto","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/microorganisms9061221","article-title":"A large case series of Neurocysticercosis in Kuwait, a nonendemic Arabian gulf country in the Middle East region","volume":"9","author":"Iqbal","year":"2021","journal-title":"Microorganisms"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1212\/01.wnl.0000142979.98182.ff","article-title":"Neurocysticercosis in the United States: review of an important emerging infection","volume":"63","author":"Wallin","year":"2004","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MD.0b013e318206d13e","article-title":"Neurocysticercosis in Houston, Texas: an update","volume":"90","author":"Serpa","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1179\/2047773212Y.0000000028","article-title":"Neurocysticercosis in the United States","volume":"106","author":"Serpa","year":"2012","journal-title":"Pathog Glob Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1017\/s0317167100013445","article-title":"A review of cases of human cysticercosis in Canada","volume":"39","author":"Del Brutto","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"8174240","DOI":"10.1155\/2020\/8174240","article-title":"The burden of Neurocysticercosis at a single New York hospital","volume":"2020","author":"Spallone","year":"2020","journal-title":"J Pathog"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/2347-8659.160865","article-title":"Neurocysticercosis in Nepal: a retrospective clinical analysis","volume":"2","author":"Ojha","year":"2015","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/acem.12508","article-title":"Computed tomography abnormalities and epidemiology of adult patients presenting with first seizure to the emergency department in Qatar","volume":"21","author":"Pathan","year":"2014","journal-title":"Acad Emerg Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yebeh.2016.07.043","article-title":"Epilepsy in Qatar: causes, treatment, and outcome","volume":"63","author":"Haddad","year":"2016","journal-title":"Epilepsy Behav"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"DC06","DOI":"10.7860\/JCDR\/2015\/12609.5967","article-title":"Imaging and serological-evidence of Neurocysticercosis among patients with seizures in Odisha, an unexplored eastern Coastal Province in India","volume":"9","author":"Sahu","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1590\/s0004-282x1997000300001","article-title":"Neurocysticercosos in South-Central America and the Indian subcontinent A comparative evaluation","volume":"55","author":"Singh","year":"1997","journal-title":"Arq Neuropsiquiatr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.trstmh.2010.01.005","article-title":"Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors","volume":"104","author":"Fleury","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0005130","DOI":"10.1371\/journal.pntd.0005130","article-title":"Cysticercosis working Group in Peru. High prevalence of asymptomatic Neurocysticercosis in an endemic rural community in Peru","volume":"10","author":"Moyano","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yebeh.2017.08.008","article-title":"Clinical presentation of neurocysticercosis-related epilepsy","volume":"76","author":"Duque","year":"2017","journal-title":"Epilepsy Behav"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/155005949903000106","article-title":"Correlation of electroencephalography and the active and inactive forms of neurocysticercosis","volume":"30","author":"Chayasirisobhon","year":"1999","journal-title":"Clin Electroencephalogr"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1212\/WNL.0b013e31828c2f3e","article-title":"Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the guideline development Subcommittee of the American Academy of neurology","volume":"80","author":"Baird","year":"2013","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1093\/cid\/cix1084","article-title":"Diagnosis and treatment of Neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"White","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"CD000215","DOI":"10.1002\/14651858.CD000215.pub5","article-title":"Anthelmintics for people with neurocysticercosis","volume":"2021","author":"Monk","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1212\/CON.0000000000000986","article-title":"Parasitic infections of the nervous system","volume":"27","author":"Garcia","year":"2021","journal-title":"Continuum (Minneap Minn)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ane.13355","article-title":"Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis","volume":"143","author":"Santhosh","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"ref36","first-page":"CD009027","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","volume-title":"Cochrane Database Syst Rev","author":"Walton","year":"2021"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yebeh.2019.07.024","article-title":"Prevalence, clinical characteristics, and seizure outcomes of epilepsy due to calcific clinical stage of neurocysticercosis: study in a rural community in South India","volume":"98","author":"Murthy","year":"2019","journal-title":"Epilepsy Behav"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/epi.13130","article-title":"Neurocysticercosis: an uncommon cause of drug-refractory epilepsy in north Indian population","volume":"56","author":"Goyal","year":"2015","journal-title":"Epilepsia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/jnnp.2005.078675","article-title":"Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients","volume":"77","author":"Velasco","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1173909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T10:44:03Z","timestamp":1681987443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1173909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":40,"alternative-id":["10.3389\/fneur.2023.1173909"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1173909","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"article-number":"1173909"}}